Eric Halioua

Eric Halioua

Company: PDC*line Pharma

Job title: President & Chief Executive Officer


Reporting Clinical Data from a First-in-Class Plasmacytoid Dendritic Cell Line Vaccine in Patients with Metastatic NSCLC 2:30 pm

Exploring the features and potential applications of the innovative PDC*vac technology as a novel cancer vaccine Unveiling new clinical safety and efficacy data from the most recent cohort of patients with NSCLC to support prior findings Using recent findings to direct future research and accelerate the treatment of patients with advanced solid tumorsRead more

day: Clinical Track Day One PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.